IOBT: 25-NSE · delisting
IO Biotech, Inc. has filed Form 25-NSE to notify the SEC of its delisting from The Nasdaq Stock Market. The delisting is effective at the opening of the trading session on June 18, 2026. Nasdaq Staff determined that the company no longer qualified for listing under Rules 5101, 5110(b), and IM-5101-1. The company was notified of this determination on March 31, 2026, but did not appeal the decision. The company's common stock was previously suspended on April 7, 2026, at which point the delisting determination became final. This marks the end of the company's listing on a major national exchange.
